Ubiquitome’s mission is to enable universal access to genomic information through ubiquitous cloud connected, genetic analysis devices.
Ubiquitome – ubiquitous cloud connected, genetic analysis devices
Cristal Therapeutics is a clinical stage biopharma company developing the next generation nanomedicines based on its proprietary CriPec platform to treat various diseases, including cancer.
Cristal Therapeutics – next generation nanomedicines
PharmaCell is a leading European-based Contract Manufacturing Organization (CMO) exclusively focused in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I through Phase III clinical trials and early commercial manufacturing in cell therapy in terms of manufacturing, Quality Control, storage, in-outgoing logistics and product release.
PharmaCell – cell therapy and regenerative medicine CMO
CiMaas BV is a biotech company developing cellular immunotherapy for specific groups of cancer patients. CiMaas focuses on the development of two unique products: a cancer vaccine using the patient’s own immune (dendritic) cells and the production of donor natural killer cells. These methods can help to treat many oncological diseases.
CiMaas – cellular immonotherapy
SkylineDx is an innovative biotech company specialized in the development and commercialization of genetic tests.
SkylineDx – innovative signature-based diagnostic tests
Amarna Therapeutics is biotech company developing a next-generation viral vector platform playing a key role in transforming treatment across many disease areas.
Amarna – next-generation viral vector platform
Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.
Mymetics – virosomes based vaccines
Agendia is a leading molecular diagnostics company developing FFPE-based genomic diagnostic products, allowing clinically relevant gene expression profiling for cancer patients.